FACULTY
Karl Doghramji, MD, FAASM, DFAPA
Professor of Psychiatry and Human Behavior
Thomas Jefferson University
Jefferson Sleep Disorders Center
Philadelphia, PA
Nancy Foldvary-Schaefer, DO, MS
Professor of Neurology, Cleveland Clinic Lerner College of Medicine
Sleep Disorders and Epilepsy Centers
Neurological Institute Cleveland Clinic
Cleveland, OH
PROGRAM OVERVIEW
Welcome to an enlightening enduring activity dedicated to elevating the knowledge and skill set of cardiologists in managing patients with idiopathic hypersomnia (IH) and narcolepsy. As vital members of the multidisciplinary team (MDT), cardiologists play a crucial role in addressing the unique challenges presented by these sleep disorders. This symposium specifically aims to enrich your understanding of the cardiovascular risks associated with IH and narcolepsy, empowering you to implement evidence-based treatment strategies that prioritize patient safety and well-being.
The education will seek to help HCPs better assess the burden of IH and narcolepsy, including the major cardiovascular risks comorbid with IH and narcolepsy; summarize the importance of limiting sodium intake to manage cardiovascular risk in patients with IH and narcolepsy, including through use of lower-sodium oxybate; and justify the importance of a multidisciplinary shared decision-making approach in patients with IH and narcolepsy to ensure optimal clinical management.
TARGET AUDIENCE
This educational activity is designed to meet the needs of cardiologists, who are an essential part of the multidisciplinary team (MDT) of specialists managing idiopathic hypersomnia and narcolepsy.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Assess the burden of IH and narcolepsy, including the major cardiovascular risks comorbid with these conditions.
- Summarize the importance of limiting sodium intake to manage cardiovascular risk in patients with IH and narcolepsy, including through use of lower-sodium oxybate.
- Justify the importance of a multidisciplinary shared decision-making approach in patients with IH and narcolepsy to ensure optimal clinical management.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Faculty Member | Disclosures | |
| Karl Doghramji, MD | Consulting fees | Axsome Therapeutics, Biogen, Harmony Biosciences, Idorsia Pharmaceuticals, Janssen, and Jazz Pharmaceuticals |
| Contracted research | Inspire, Nyxoah, Respicardia, and Sommetrics | |
| Ownership interest | Merck | |
| Nancy Foldvary-Schaefer, DO, MS | Contracted research | Harmony Biosciences, Jazz Pharmaceuticals, Takeda Pharmaceuticals, Suven Life Sciences |
| Royalties | Oxford University Press, UpToDate | |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
- Joan Duer-Hefele, RN, MA, CCRC, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Christopher J. Drury, MA, MS, MBA, Medical Director for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Daniel DaSilva, Accreditation and Outcomes Coordinator for Med Learning Group has nothing to disclose.
- Felecia Beachum, Sr. Program Manager for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: December 03, 2024
EXPIRATION DATE: December 03, 2025
Copyright © 2024 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
